Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MNPR | AMGN | BMY | VRTX | GILD |
| Company | Monopar Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.88 | 290.84 | 58.35 | 454.30 | 89.81 |
| High | 20.21 | 295.48 | 58.79 | 457.54 | 90.49 |
| Low | 19.54 | 288.78 | 57.62 | 449.04 | 89.27 |
| Last | 19.84 | 294.63 | 58.74 | 451.18 | 90.24 |
| Change | +0.13 | +4.73 | +0.51 | +0.81 | +0.48 |
| % Change | +0.63% | +1.63% | +0.88% | +0.18% | +0.53% |
| Volume | 21,113 | 1,443,446 | 4,000,468 | 765,629 | 1,950,090 |
| 20-Day Average Volume | 319,394 | 2,910,641 | 12,234,043 | 1,331,114 | 7,334,566 |
| Previous Close | 19.71 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.22 | 306.31 | 56.26 | 477.91 | 90.96 |
| 20-Day Raw Stochastic | 76.60% | 36.42% | 74.00% | 8.27% | 33.54% |
| 20-Day Relative Strength | 62.59% | 40.30% | 61.71% | 41.23% | 54.93% |
| Weighted Alpha | +73.85 | +4.26 | +27.35 | +18.36 | +27.27 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.18% since 11/15/24 | +3.93% since 11/15/24 | +4.36% since 11/15/24 | -3.12% since 11/15/24 | +2.24% since 11/15/24 |
| Low | 17.52 on 11/18/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 21.18 on 11/20/24 | 295.48 on 11/22/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.46 on 11/22/24 |
| 1-Month | |||||
| %Chg | +276.19% since 10/22/24 | -7.79% since 10/22/24 | +11.20% since 10/22/24 | -4.99% since 10/22/24 | +2.52% since 10/22/24 |
| Low | 4.50 on 10/23/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 38.50 on 10/24/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +615.58% since 08/22/24 | -9.18% since 08/22/24 | +23.20% since 08/22/24 | -5.98% since 08/22/24 | +19.08% since 08/22/24 |
| Low | 2.25 on 08/29/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 38.50 on 10/24/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +542.69% since 05/22/24 | -4.74% since 05/22/24 | +38.57% since 05/22/24 | +0.82% since 05/22/24 | +33.30% since 05/22/24 |
| Low | 1.72 on 08/12/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 38.50 on 10/24/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,025 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 5,278 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -8,400,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -1,300,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.09 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/08/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |